Biodel Spikes on Heavy Volume

Shares of Biodel Inc. (BIOD) rose 27 percent to $2.49 and rallied 30 percent earlier. The biotech company is expected to issue a corporate update at J.P. Morgan’s annual health-care conference in San Francisco. The update will include information about the development of new follow-on formulations of its lead product, Linjeta including milestones and timelines, according to a press release.

Shares of BIOD traded as high as $2.69 during mid-day trading on Thursday. Over the last two months, the security has gained 40%, but still remains at depressed levels, having fallen more than 60.80% in the last 52 weeks. The day’s trading range for shares of Biodel Inc., which closed at $1.96 in the previous trading session and opened today at $2.01, has been between $1.96 and $2.69 per share. The median Wall Street price target on the stock is $4.50 and the high target is set at $7.00.

The security’s volume has swelled to more than seven times the stock’s daily average. More than 7.7 million BIOD shares have already traded hands compared to a daily average of around 994,000.

At last check [2:02 p.m. EST], BIOD shares  were up over 25% to $2.45 in trading on the Nasdaq. In the past year, Biodel Inc has hit a 52-week low of $1.50 and 52-week high of $6.25.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

About Ron Haruni 1070 Articles
Ron Haruni is the Co-Founder & Editor in Chief of Wall Street Pit.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.